BiotechTube
Home/Quince Therapeutics/Michael D. K. Bigham
MD

Michael D. K. Bigham

Chairman of the Board

Quince Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesInflammatory Diseases

Quince Therapeutics Pipeline

DrugIndicationPhase
EQ101Alzheimer's DiseasePhase 1

Leadership Team at Quince Therapeutics

DT
Dirk Thye, M.D.
Chief Executive Officer and Director
EL
Erin L. Bales
Chief Commercial Officer
CK
Christopher Krueger, J.D.
Chief Business Officer and General Counsel
HE
Halley E. Gilbert
Chief Operating Officer
SH
Sharon Hall
Chief Financial Officer (Interim)
CC
Casey C. Lynch
Co-Founder and Director
SL
Stephen L. Dominy, M.D.
Co-Founder and Director
RD
Robert D. Hoffman
Director
WD
William D. Young
Director
AL
Alison Lawton
Director
View full Quince Therapeutics profile